To further define the role of PI3K/AKT/mTOR signaling pathway affected by ILF3 in the regulation of GC cell proliferation, cell cycle, migration, and invasion, the malignant biological of GC cells overexpressing ILF3 treated with PI3K/AKT inhibitor LY294002. This evidence concerns the gene ILF3 and gastric cancer.